Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $4.33 million. The enterprise value is $275,097.

Market Cap	4.33M
Enterprise Value	275,097

Important Dates

The last earnings date was Tuesday, March 17, 2026, after market close.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

SLXN has 3.33 million shares outstanding. The number of shares has increased by 7,975.29% in one year.

Current Share Class	3.13M
Shares Outstanding	3.33M
Shares Change (YoY)	+7,975.29%
Shares Change (QoQ)	+177.79%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	1.26%
Float	2.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.53
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.78.

Current Ratio	2.41
Quick Ratio	2.17
Debt / Equity	0.78
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-894.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-144.27%
Return on Invested Capital (ROIC)	-282.82%
Return on Capital Employed (ROCE)	-260.98%
Weighted Average Cost of Capital (WACC)	2.89%
Revenue Per Employee	n/a
Profits Per Employee	-$850,857
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SLXN has paid $3,000 in taxes.

Income Tax	3,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.40% in the last 52 weeks. The beta is -0.04, so SLXN's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-92.40%
50-Day Moving Average	1.76
200-Day Moving Average	5.14
Relative Strength Index (RSI)	34.18
Average Volume (20 Days)	34,796

Short Selling Information

The latest short interest is 45,388, so 1.36% of the outstanding shares have been sold short.

Short Interest	45,388
Short Previous Month	55,759
Short % of Shares Out	1.36%
Short % of Float	1.53%
Short Ratio (days to cover)	1.42

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.63M
Pretax Income	-11.91M
Net Income	-11.91M
EBITDA	-11.62M
EBIT	-11.63M
Earnings Per Share (EPS)	-$8.96

Balance Sheet

The company has $5.99 million in cash and $2.04 million in debt, with a net cash position of $3.96 million or $1.19 per share.

Cash & Cash Equivalents	5.99M
Total Debt	2.04M
Net Cash	3.96M
Net Cash Per Share	$1.19
Equity (Book Value)	2.60M
Book Value Per Share	0.83
Working Capital	3.88M

Cash Flow

In the last 12 months, operating cash flow was -$10.82 million and capital expenditures -$9,000, giving a free cash flow of -$10.83 million.

Operating Cash Flow	-10.82M
Capital Expenditures	-9,000
Depreciation & Amortization	14,000
Net Borrowing	-696,000
Free Cash Flow	-10.83M
FCF Per Share	-$3.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7,975.29%
Shareholder Yield	-7,975.29%
Earnings Yield	-281.60%
FCF Yield	-255.98%

Analyst Forecast

The average price target for SLXN is $40.50, which is 3,015.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.50
Price Target Difference	3,015.39%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-57.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 29, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jul 29, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	3